Ascendis Pharma A (ASND) EPS (Basic) (2014 - 2026)
Ascendis Pharma A (ASND) posted EPS (Basic) of $12.22 for Q1 2026, up 1967.84% sequentially from -$0.65 in Q4 2025, and up 836.02% YoY from $1.31 in Q1 2025.
Powered by 
Analysis
Ascendis Pharma A (ASND) EPS (Basic) (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported EPS (Basic) for 13 years, with the latest figure at $12.22 in Q1 2026.
- Quarterly EPS (Basic) rose 836.02% year-over-year to $12.22 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.11 (up 675.07% YoY) and the FY2025 annual result came in at -$4.45, up 36.27% from the prior year.
- EPS (Basic) improved to $12.22 in Q1 2026 per ASND's latest filing, from -$0.65 in the prior quarter.
- Over five years, EPS (Basic) peaked at $12.22 in Q1 2026 and troughed at -$3.77 in Q4 2022.
- A 5-year average of $1.08 and a median of $1.57 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) slumped 278.25% in 2022, then soared 836.02% in 2026.
- Over 5 years, EPS (Basic) stood at -$3.77 in 2022, then soared by 55.24% to -$1.69 in 2023, then jumped by 57.97% to -$0.71 in 2024, then rose by 7.9% to -$0.65 in 2025, then soared by 1967.84% to $12.22 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $12.22, -$0.65, and -$1.2 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Ascendis Pharma A | 16.39 Bn | 15.45 Bn | 362.22 Mn | 0.09 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.09 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | -0.64 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | -8.07 |
| Sep 30, 2021 | 0.02 |